Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

88% phenol is effective for treating alopecia areata.

Alopecia Areata causes significant structural and compositional changes in hair.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Lack of vitamin D might cause hair loss due to autoimmune problems, and fixing vitamin D levels could help treat it.